Robert W. Baird Lowers Cigna Group (NYSE:CI) Price Target to $315.00

Cigna Group (NYSE:CI) had its price target lowered by stock analysts at Robert W. Baird from $372.00 to $315.00 in a note issued to investors on Thursday,MarketScreener reports. The brokerage currently has an “outperform” rating on the health services provider’s stock. Robert W. Baird’s target price would indicate a potential upside of 18.18% from the company’s previous close.

Other research analysts also recently issued reports about the stock. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research report on Monday. Leerink Partners lowered their price objective on shares of Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Cowen reissued a “buy” rating on shares of Cigna Group in a report on Friday, December 5th. Wells Fargo & Company decreased their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 5th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $331.77.

Cigna Group Price Performance

Shares of CI opened at $266.54 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market cap of $71.20 billion, a price-to-earnings ratio of 11.77, a PEG ratio of 0.95 and a beta of 0.26. The stock has a 50 day moving average of $281.66 and a 200-day moving average of $294.61.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same period in the prior year, the company posted $7.51 EPS. The business’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Insider Buying and Selling

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Valeo Financial Advisors LLC grew its position in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares in the last quarter. Norges Bank bought a new stake in shares of Cigna Group during the 2nd quarter worth about $1,110,426,000. Capital Research Global Investors lifted its stake in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Cigna Group by 54.5% in the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.